First Midwest Bank Trust Division’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-12,322
Closed -$87K 392
2021
Q1
$87K Hold
12,322
0.01% 372
2020
Q4
$59K Hold
12,322
0.01% 352
2020
Q3
$72K Hold
12,322
0.01% 351
2020
Q2
$83K Hold
12,322
0.01% 342
2020
Q1
$78K Hold
12,322
0.01% 334
2019
Q4
$128K Sell
12,322
-195,771
-94% -$1.42M 0.02% 351
2019
Q3
$818K Buy
+208,093
New +$1.68M 0.12% 187
2016
Q2
Sell
-25,459
Closed -$489K 455
2016
Q1
$489K Buy
25,459
+250
+1% +$5.29K 0.06% 255
2015
Q4
$882K Buy
+25,209
New +$1.63M 0.15% 153

Other funds holding CLVS

First Midwest Bank Trust Division's CLVS Position: Q2 2021 in Review

First Midwest Bank Trust Division sold out of Clovis Oncology, Inc. (CLVS) in Q2 2021, closing a stake of 12,322 shares — an estimated $87K sold.

First Midwest Bank Trust Division first reported a position in CLVS in Q4 2015 and held it in 9 quarters. The position peaked at $882K in Q4 2015. 160 funds tracked by Wall St. Rank hold CLVS as of Q2 2021.

  • First Midwest Bank Trust Division reported no remaining Clovis Oncology, Inc. position as of Q2 2021 after selling out during the quarter.
  • First Midwest Bank Trust Division sold 12,322 Clovis Oncology, Inc. shares in Q2 2021, an estimated $87K.
  • First Midwest Bank Trust Division first reported a position in Clovis Oncology, Inc. in Q4 2015 and held it in 9 quarters.
  • First Midwest Bank Trust Division's Clovis Oncology, Inc. position peaked at $882K in Q4 2015.
  • 160 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q2 2021, filed 8 Jul 2021.